Nifty

:

25795.15

Sensex

:

84211.88

-96.25 (-0.37%)
-344.52 (-0.41%)

Login

Nifty
Sensex

:
:

25795.15
84211.88

-96.25 (-0.37%)
-344.52 (-0.41%)

Rossari Biotech Ltd.

Chemicals

Rating :

54/99

BSE: 543213 | NSE: ROSSARI

Watchlist

NSE BSE

650.40

24-Oct-2025

Open
High
Low
Previous Close

652
653.3
642.9
650.95

Volume
Traded Value (lacs)
52 Week High
52 Week Low

27938
18140515.45
884.7
569

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,603.67
26.38
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,875.53
0.08%
2.88

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

27.82
24.01
7.90

EBITDA CAGR (%)

10 Years
5 Years
3 Years

35.13
15.61
3.45

PAT CAGR (%)

10 Years
5 Years
3 Years

44.70
11.31
8.34

P:E (Median)

8 Years
5 Years
3 Years

-
41.54
33.71

P:BV (Average)

8 Years
5 Years
3 Years

-
6.20
4.08

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
26.12
16.98

Earnings Forecasts:

(Updated: 25-10-2025)

Description 2024 2025 2026 2027
Adj EPS 24.66 28.54 35.85 42.81
P/E Ratio 26.37 22.79 18.14 15.19
Revenue 2080.29 2361.25 2747.55 3231.37
EBITDA 265.08 303.38 366.72 431.5
Net Income 136.38 157.98 198.8 236.73
ROA 7.86 7.99 8.46 8.9
P/B Ratio 3.04 2.70 2.39 2.13
ROE 12.21 12.5 13.97 14.1
FCFF -33.97 -74.03 20.51 161.38
FCFF Yield -0.9 -1.97 0.55 4.29
Net Debt 103.52 173.2 129.35 32.45
BVPS 214.12 240.61 272.7 304.98

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 419.51 335.99 24.86% 365.76 300.71 21.63% 426.65 313.80 35.96% 368.28 298.75 23.27%
Expenses 369.10 291.72 26.53% 321.81 260.90 23.35% 374.45 272.08 37.62% 318.32 257.61 23.57%
EBITDA 50.41 44.27 13.87% 43.94 39.80 10.40% 52.20 41.72 25.12% 49.96 41.14 21.44%
EBIDTM 12.02% 13.18% 12.01% 13.24% 12.23% 13.30% 13.57% 13.77%
Other Income 1.40 1.08 29.63% 1.74 1.26 38.10% 2.40 1.34 79.10% 1.01 2.13 -52.58%
Interest 2.49 1.90 31.05% 3.09 2.33 32.62% 3.08 1.74 77.01% 2.28 2.63 -13.31%
Depreciation 7.34 6.54 12.23% 7.15 6.06 17.99% 7.66 6.58 16.41% 7.43 5.84 27.23%
PBT 41.97 36.91 13.71% 35.44 32.67 8.48% 43.86 34.74 26.25% 41.26 34.80 18.56%
Tax 10.72 9.49 12.96% 9.21 8.34 10.43% 11.49 8.58 33.92% 10.63 9.26 14.79%
PAT 31.25 27.42 13.97% 26.23 24.33 7.81% 32.36 26.17 23.65% 30.63 25.54 19.93%
PATM 7.45% 8.16% 7.17% 8.09% 7.59% 8.34% 8.32% 8.55%
EPS 5.64 4.95 13.94% 4.74 4.39 7.97% 5.84 4.72 23.73% 5.53 4.61 19.96%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 586.11 498.35 17.61% 543.72 489.65 11.04% 579.56 472.71 22.60% 512.73 463.77 10.56%
Expenses 514.18 432.41 18.91% 475.86 424.76 12.03% 510.07 409.12 24.67% 447.97 400.10 11.96%
EBITDA 71.92 65.94 9.07% 67.86 64.89 4.58% 69.49 63.59 9.28% 64.76 63.67 1.71%
EBIDTM 12.27% 13.23% 12.48% 13.25% 11.99% 13.45% 12.63% 13.73%
Other Income 1.60 0.72 122.22% 1.20 0.95 26.32% 1.79 0.39 358.97% 0.55 3.50 -84.29%
Interest 6.09 3.68 65.49% 5.73 3.69 55.28% 5.50 2.52 118.25% 4.94 4.32 14.35%
Depreciation 18.23 15.16 20.25% 17.75 15.37 15.48% 18.22 16.07 13.38% 18.32 15.09 21.40%
PBT 49.20 47.82 2.89% 45.58 46.78 -2.57% 47.56 45.39 4.78% 42.05 47.76 -11.96%
Tax 12.80 12.78 0.16% 12.50 12.09 3.39% 13.26 11.44 15.91% 10.68 13.39 -20.24%
PAT 36.41 35.04 3.91% 33.08 34.69 -4.64% 34.30 33.95 1.03% 31.37 34.37 -8.73%
PATM 6.21% 7.03% 6.08% 7.08% 5.92% 7.18% 6.12% 7.41%
EPS 6.66 6.39 4.23% 6.07 6.32 -3.96% 6.22 6.18 0.65% 5.73 6.23 -8.03%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,580.20 1,431.63 1,202.91 975.17 1,072.84 690.41 600.09 515.92 291.79 233.38 178.08 Net Sales Growth 26.49% 19.01% 23.35% -9.10% 55.39% 15.05% 16.31% 76.81% 25.03% 31.05% Cost Of Goods Sold 1,161.67 1,047.08 897.14 704.31 822.68 451.64 371.70 339.27 196.45 165.34 130.41 Gross Profit 418.53 384.55 305.77 270.86 250.16 238.77 228.39 176.65 95.34 68.04 47.67 GP Margin 26.49% 26.86% 25.42% 27.78% 23.32% 34.58% 38.06% 34.24% 32.67% 29.15% 26.77% Total Expenditure 1,383.68 1,254.02 1,045.88 855.07 953.12 569.56 495.09 438.28 247.21 208.88 165.78 Power & Fuel Cost - 3.41 3.01 2.80 2.80 2.40 1.74 1.26 1.71 1.48 0.79 % Of Sales - 0.24% 0.25% 0.29% 0.26% 0.35% 0.29% 0.24% 0.59% 0.63% 0.44% Employee Cost - 60.01 51.46 57.35 43.53 36.66 37.13 27.42 19.53 14.13 11.44 % Of Sales - 4.19% 4.28% 5.88% 4.06% 5.31% 6.19% 5.31% 6.69% 6.05% 6.42% Manufacturing Exp. - 29.18 23.63 20.64 21.75 16.64 26.64 27.82 2.35 7.93 3.32 % Of Sales - 2.04% 1.96% 2.12% 2.03% 2.41% 4.44% 5.39% 0.81% 3.40% 1.86% General & Admin Exp. - 40.09 31.31 26.38 20.48 13.09 16.76 13.62 9.90 7.37 2.26 % Of Sales - 2.80% 2.60% 2.71% 1.91% 1.90% 2.79% 2.64% 3.39% 3.16% 1.27% Selling & Distn. Exp. - 63.27 28.95 33.24 28.77 35.98 33.96 24.43 9.58 6.61 3.99 % Of Sales - 4.42% 2.41% 3.41% 2.68% 5.21% 5.66% 4.74% 3.28% 2.83% 2.24% Miscellaneous Exp. - 10.99 10.37 10.34 13.12 13.15 7.16 4.45 7.68 6.02 3.99 % Of Sales - 0.77% 0.86% 1.06% 1.22% 1.90% 1.19% 0.86% 2.63% 2.58% 7.61% EBITDA 196.51 177.61 157.03 120.10 119.72 120.85 105.00 77.64 44.58 24.50 12.30 EBITDA Margin 12.44% 12.41% 13.05% 12.32% 11.16% 17.50% 17.50% 15.05% 15.28% 10.50% 6.91% Other Income 6.55 14.37 11.00 6.14 15.77 10.21 3.63 1.27 0.94 0.62 0.44 Interest 10.94 9.58 9.70 4.62 2.54 2.99 3.68 3.27 0.99 2.12 3.43 Depreciation 29.58 27.69 24.19 25.98 26.27 22.07 16.85 12.19 5.10 4.27 4.50 PBT 162.53 154.70 134.13 95.64 106.68 106.00 88.11 63.45 39.43 18.73 4.80 Tax 42.05 39.96 34.49 24.25 27.21 26.90 22.59 17.66 10.51 3.14 1.39 Tax Rate 25.87% 25.83% 25.71% 25.36% 25.51% 25.38% 25.64% 27.83% 26.65% 16.76% 28.96% PAT 120.47 114.74 99.64 71.39 79.47 79.10 65.52 45.79 28.92 15.59 3.42 PAT before Minority Interest 120.47 114.74 99.64 71.39 79.47 79.10 65.52 45.79 28.92 15.59 3.42 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.62% 8.01% 8.28% 7.32% 7.41% 11.46% 10.92% 8.88% 9.91% 6.68% 1.92% PAT Growth 16.44% 15.15% 39.57% -10.17% 0.47% 20.73% 43.09% 58.33% 85.50% 355.85% EPS 21.75 20.71 17.99 12.89 14.34 14.28 11.83 8.27 5.22 2.81 0.62

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 16 Mar 15
Net Sales 2,222.12 2,080.29 1,830.56 1,655.88 1,482.97 709.35 600.09 516.22 291.80 178.66 171.07 Net Sales Growth 15.47% 13.64% 10.55% 11.66% 109.06% 18.21% 16.25% 76.91% 63.33% 4.44% Cost Of Goods Sold 1,523.90 1,433.30 1,293.52 1,171.32 1,107.79 462.20 371.70 339.27 196.56 130.58 123.41 Gross Profit 698.22 647.00 537.03 484.57 375.18 247.15 228.39 176.95 95.24 48.07 47.65 GP Margin 31.42% 31.10% 29.34% 29.26% 25.30% 34.84% 38.06% 34.28% 32.64% 26.91% 27.85% Total Expenditure 1,948.08 1,826.10 1,587.48 1,441.32 1,306.68 586.29 495.35 438.67 247.14 166.14 156.49 Power & Fuel Cost - 25.91 23.30 20.40 11.91 2.40 1.74 1.26 0.85 0.80 0.64 % Of Sales - 1.25% 1.27% 1.23% 0.80% 0.34% 0.29% 0.24% 0.29% 0.45% 0.37% Employee Cost - 132.33 103.13 98.62 67.93 41.98 37.21 27.52 19.61 11.53 11.36 % Of Sales - 6.36% 5.63% 5.96% 4.58% 5.92% 6.20% 5.33% 6.72% 6.45% 6.64% Manufacturing Exp. - 51.03 40.62 28.23 25.67 18.88 26.64 27.82 2.35 3.28 3.32 % Of Sales - 2.45% 2.22% 1.70% 1.73% 2.66% 4.44% 5.39% 0.81% 1.84% 1.94% General & Admin Exp. - 64.44 43.51 36.13 25.14 14.74 16.83 13.64 10.78 1.38 5.89 % Of Sales - 3.10% 2.38% 2.18% 1.70% 2.08% 2.80% 2.64% 3.69% 0.77% 3.44% Selling & Distn. Exp. - 94.75 64.36 67.50 48.37 34.74 33.96 24.43 9.58 3.05 7.52 % Of Sales - 4.55% 3.52% 4.08% 3.26% 4.90% 5.66% 4.73% 3.28% 1.71% 4.40% Miscellaneous Exp. - 24.35 19.03 19.14 19.86 11.36 7.27 4.73 7.41 15.51 7.52 % Of Sales - 1.17% 1.04% 1.16% 1.34% 1.60% 1.21% 0.92% 2.54% 8.68% 2.54% EBITDA 274.03 254.19 243.08 214.56 176.29 123.06 104.74 77.55 44.66 12.52 14.58 EBITDA Margin 12.33% 12.22% 13.28% 12.96% 11.89% 17.35% 17.45% 15.02% 15.31% 7.01% 8.52% Other Income 5.14 14.90 14.12 13.95 19.14 9.19 3.72 0.91 1.41 0.38 0.30 Interest 22.26 17.81 19.37 22.32 12.66 2.99 3.56 2.88 1.36 3.53 5.05 Depreciation 72.52 67.07 60.39 62.93 48.05 22.83 16.85 12.19 5.16 4.52 5.09 PBT 184.39 184.21 177.44 143.26 134.73 106.43 88.06 63.39 39.55 4.85 4.75 Tax 49.24 48.81 46.93 36.96 38.58 26.79 22.59 17.71 10.53 1.47 1.02 Tax Rate 26.70% 26.50% 26.45% 25.80% 28.64% 25.17% 25.65% 27.94% 26.62% 30.31% 21.47% PAT 135.16 136.38 130.69 107.26 97.67 79.81 65.47 45.68 29.01 3.39 3.73 PAT before Minority Interest 135.16 136.38 130.69 107.26 97.69 79.64 65.47 45.68 29.01 3.39 3.73 Minority Interest 0.00 0.00 0.00 0.00 -0.02 0.17 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.08% 6.56% 7.14% 6.48% 6.59% 11.25% 10.91% 8.85% 9.94% 1.90% 2.18% PAT Growth -2.09% 4.35% 21.84% 9.82% 22.38% 21.90% 43.32% 57.46% 755.75% -9.12% EPS 24.40 24.62 23.59 19.36 17.63 14.41 11.82 8.25 5.24 0.61 0.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,077.17 960.34 858.70 784.52 404.44 283.47 120.34 89.51 60.59 45.26 Share Capital 11.07 11.05 11.03 11.01 10.39 10.15 4.40 4.40 4.40 4.40 Total Reserves 1,063.76 945.61 844.16 770.23 391.94 272.84 115.94 85.11 56.19 40.86 Non-Current Liabilities 69.56 90.14 90.71 56.95 57.68 69.07 37.18 3.53 4.60 6.26 Secured Loans 0.00 24.94 34.93 0.00 0.00 33.96 0.67 1.29 2.43 6.52 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 59.81 58.59 57.74 57.97 57.73 34.57 34.70 0.00 0.00 0.00 Current Liabilities 505.00 394.54 306.29 191.08 165.62 168.83 123.91 66.10 55.96 52.03 Trade Payables 285.93 225.87 177.65 115.81 123.64 96.99 105.97 38.06 31.79 28.35 Other Current Liabilities 25.03 27.58 24.33 18.11 13.76 20.32 12.21 5.53 1.84 6.66 Short Term Borrowings 30.14 20.13 20.00 0.00 0.00 27.05 5.13 19.63 21.20 15.44 Short Term Provisions 163.91 120.96 84.31 57.16 28.23 24.47 0.60 2.88 1.14 1.58 Total Liabilities 1,651.73 1,445.02 1,255.70 1,032.55 627.74 521.37 281.43 159.14 121.15 103.55 Net Block 179.20 167.29 157.06 177.38 170.75 93.54 74.00 43.74 36.89 35.96 Gross Block 322.58 283.48 256.21 251.36 220.34 122.47 86.19 84.18 72.37 67.74 Accumulated Depreciation 143.38 116.19 99.15 73.99 49.59 28.93 12.19 40.44 35.49 31.79 Non Current Assets 802.88 765.63 708.85 613.58 261.54 178.53 123.04 58.86 45.88 44.32 Capital Work in Progress 34.09 24.60 13.68 0.84 0.32 21.75 2.83 9.99 7.90 7.55 Non Current Investment 493.11 490.60 472.78 371.85 9.25 4.65 0.23 3.20 0.20 0.20 Long Term Loans & Adv. 96.45 83.12 65.28 63.41 61.57 58.17 38.59 1.94 0.89 0.62 Other Non Current Assets 0.04 0.02 0.06 0.11 19.65 0.42 7.39 0.00 0.00 0.00 Current Assets 847.64 678.17 545.63 418.96 366.21 342.84 158.38 100.27 75.28 59.23 Current Investments 45.29 37.56 20.31 9.01 0.00 10.56 0.00 0.00 0.00 0.00 Inventories 178.83 151.13 112.83 107.44 88.52 58.17 54.90 35.10 23.51 25.04 Sundry Debtors 374.60 301.91 243.85 180.96 137.32 93.81 85.56 59.79 47.34 28.96 Cash & Bank 16.02 25.67 80.27 34.81 85.98 127.21 5.99 0.66 1.78 2.01 Other Current Assets 232.90 1.51 2.13 4.80 54.38 53.10 11.94 4.72 2.66 3.22 Short Term Loans & Adv. 226.34 160.38 86.23 81.95 51.07 52.18 11.50 4.41 2.51 3.08 Net Current Assets 342.64 283.63 239.34 227.89 200.59 174.01 34.48 34.18 19.32 7.20 Total Assets 1,650.52 1,443.80 1,254.48 1,032.54 627.75 521.37 281.42 159.13 121.16 103.55

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 1,185.45 1,047.73 915.17 805.16 408.77 286.68 123.81 94.37 Share Capital 11.07 11.05 11.03 11.01 10.39 10.15 4.40 4.40 Total Reserves 1,172.19 1,033.14 900.63 790.87 396.27 276.04 119.41 89.97 Non-Current Liabilities 261.53 192.97 180.86 251.37 59.10 69.02 37.15 3.61 Secured Loans 100.03 33.32 34.93 0.00 0.00 33.96 0.67 1.29 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 103.13 102.07 82.35 98.75 58.12 34.57 34.71 0.00 Current Liabilities 740.38 583.93 475.66 360.24 176.88 168.85 121.80 67.64 Trade Payables 286.33 219.10 181.02 186.15 131.11 97.00 105.98 40.39 Other Current Liabilities 144.56 128.49 125.96 99.73 17.41 20.33 11.91 5.54 Short Term Borrowings 86.11 62.53 29.01 0.00 0.00 27.05 3.27 18.83 Short Term Provisions 223.38 173.82 139.67 74.36 28.35 24.47 0.63 2.88 Total Liabilities 2,187.36 1,824.63 1,571.69 1,416.77 644.75 524.55 282.76 165.62 Net Block 598.35 577.56 585.23 607.14 181.25 93.54 74.00 45.03 Gross Block 877.71 790.88 743.02 704.33 233.82 122.47 86.19 87.62 Accumulated Depreciation 279.36 213.33 157.79 97.18 52.57 28.93 12.19 42.59 Non Current Assets 940.41 820.65 723.11 741.91 263.33 178.08 122.92 60.08 Capital Work in Progress 140.19 47.21 16.08 1.34 0.32 21.75 2.83 9.99 Non Current Investment 26.49 25.28 25.18 24.37 0.00 4.17 0.00 3.00 Long Term Loans & Adv. 175.30 170.53 96.50 108.69 62.12 58.20 38.70 2.07 Other Non Current Assets 0.09 0.07 0.12 0.36 19.65 0.42 7.39 0.00 Current Assets 1,245.74 1,002.77 847.37 674.87 381.42 346.46 159.84 105.53 Current Investments 57.31 37.58 26.00 11.55 0.00 13.73 0.00 4.16 Inventories 355.08 282.33 188.48 189.93 95.35 58.17 54.90 35.10 Sundry Debtors 474.50 425.13 353.66 304.85 144.07 94.14 85.92 59.80 Cash & Bank 57.16 30.21 123.94 52.35 88.26 127.23 6.01 0.76 Other Current Assets 301.68 2.15 3.33 5.59 53.73 53.20 13.01 5.72 Short Term Loans & Adv. 298.57 225.37 151.96 110.60 52.13 52.28 12.52 5.40 Net Current Assets 505.36 418.84 371.70 314.63 204.53 177.61 38.04 37.89 Total Assets 2,186.15 1,823.42 1,570.48 1,416.78 644.75 524.54 282.76 165.61

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 14 Mar 13
Cash From Operating Activity 92.20 73.92 112.94 33.12 52.09 55.75 71.55 21.80 6.24 17.00 PBT 154.70 134.13 95.64 106.68 106.00 88.11 63.45 39.43 4.19 3.37 Adjustment 33.72 30.36 30.39 22.65 18.41 20.17 16.55 5.68 9.29 9.76 Changes in Working Capital -56.94 -55.08 11.92 -71.99 -41.38 -32.38 11.87 -12.80 -1.75 9.11 Cash after chg. in Working capital 131.48 109.41 137.95 57.34 83.02 75.90 91.87 32.31 11.73 22.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.67 -4.58 Tax Paid -39.28 -35.49 -25.01 -24.23 -30.93 -20.15 -20.32 -10.51 -0.56 -0.18 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.26 -0.48 Cash From Investing Activity -69.92 -69.55 -160.59 -318.12 -37.00 -187.25 -40.12 -16.21 3.53 9.17 Net Fixed Assets -48.59 -38.19 -17.69 -31.54 -76.44 -55.20 5.15 -24.60 -3.54 -9.17 Net Investments -10.24 -35.07 -112.23 -371.61 5.96 -14.98 2.97 -3.00 0.00 0.00 Others -11.09 3.71 -30.67 85.03 33.48 -117.07 -48.24 11.39 7.07 18.34 Cash from Financing Activity -32.27 -22.09 61.21 296.91 -29.45 154.97 -25.83 -6.28 2.89 -25.90 Net Cash Inflow / Outflow -9.99 -17.72 13.56 11.91 -14.36 23.47 5.61 -0.69 12.66 0.28 Opening Cash & Equivalents 22.55 40.50 26.74 14.83 29.19 5.73 0.61 1.78 0.51 0.23 Closing Cash & Equivalent 12.91 22.55 40.50 26.74 14.83 29.19 5.73 1.09 0.33 0.51

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 137.44 43.26 151.56 29.36 47.77 56.83 71.18 23.59 PBT 185.19 177.62 144.22 136.28 106.84 88.06 63.39 39.55 Adjustment 84.44 76.36 82.95 55.25 20.58 19.99 16.76 5.64 Changes in Working Capital -72.98 -156.85 -27.83 -112.05 -48.30 -31.07 11.39 -11.07 Cash after chg. in Working capital 196.65 97.13 199.34 79.48 79.11 76.98 91.55 34.12 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -59.20 -53.88 -47.78 -50.12 -31.35 -20.15 -20.37 -10.53 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -183.69 -103.21 -180.89 -298.88 -37.18 -190.30 -36.42 -20.49 Net Fixed Assets -48.59 -38.19 -17.69 -31.54 -76.44 -55.20 5.15 Net Investments -10.24 -35.07 -112.23 -371.61 5.96 -14.98 2.97 Others -124.86 -29.95 -50.97 104.27 33.30 -120.12 -44.54 Cash from Financing Activity 64.90 16.18 60.85 291.79 -24.59 156.94 -29.15 -4.67 Net Cash Inflow / Outflow 18.65 -43.77 31.52 22.27 -14.00 23.47 5.61 -1.57 Opening Cash & Equivalents 25.17 69.20 37.48 15.21 29.21 5.74 0.63 2.33 Closing Cash & Equivalent 44.20 25.17 69.20 37.48 15.21 29.21 5.74 0.76

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 194.14 173.17 155.05 141.90 77.48 55.76 273.50 203.44 137.70 102.86 ROA 7.41% 7.38% 6.24% 9.57% 13.77% 16.32% 20.79% 20.64% 13.88% 3.25% ROE 11.30% 11.00% 8.73% 13.43% 23.08% 32.49% 43.64% 38.54% 29.46% 7.82% ROCE 15.48% 14.84% 11.74% 18.37% 28.88% 38.47% 56.07% 41.24% 27.43% 11.32% Fixed Asset Turnover 4.74 4.49 3.89 4.59 4.09 5.78 6.06 3.82 3.68 2.95 Receivable days 85.98 82.27 78.44 53.67 60.12 54.28 51.38 65.46 54.01 50.29 Inventory Days 41.93 39.79 40.67 33.04 38.16 34.21 31.81 35.81 34.37 52.98 Payable days 89.20 82.09 76.04 53.12 89.15 76.09 58.63 53.85 54.74 57.88 Cash Conversion Cycle 38.71 39.97 43.08 33.59 9.13 12.40 24.56 47.42 33.64 45.40 Total Debt/Equity 0.03 0.06 0.08 0.00 0.00 0.24 0.05 0.24 0.40 0.49 Interest Cover 17.14 14.83 21.71 42.92 36.43 24.96 20.42 40.86 9.82 2.40

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 16 Mar 15
Book Value (Rs.) 213.72 189.01 165.29 145.65 78.31 56.39 281.39 214.47 113.64 106.56 ROA 6.80% 7.70% 7.18% 9.48% 13.62% 16.22% 20.38% 20.00% 3.04% 3.11% ROE 12.25% 13.36% 12.52% 16.17% 22.99% 31.94% 41.88% 36.33% 6.99% 8.18% ROCE 16.07% 18.39% 18.48% 24.37% 28.70% 38.02% 54.40% 40.37% 10.30% 10.70% Fixed Asset Turnover 2.50 2.40 2.30 3.18 4.01 5.78 5.94 3.65 3.41 2.54 Receivable days 78.74 77.31 72.29 55.00 60.78 54.48 51.48 65.53 61.97 61.77 Inventory Days 55.79 46.74 41.54 34.95 39.17 34.21 31.80 35.88 57.73 78.22 Payable days 64.36 56.45 57.21 52.27 90.07 76.09 59.57 55.94 57.81 59.03 Cash Conversion Cycle 70.18 67.59 56.62 37.69 9.88 12.61 23.70 45.47 61.89 80.96 Total Debt/Equity 0.16 0.10 0.08 0.01 0.00 0.23 0.04 0.22 0.45 0.93 Interest Cover 11.40 10.17 7.46 11.77 36.57 25.76 23.03 30.15 2.38 1.94

Top Investors:

uti-flexi cap fund

life insurance corporation of india

sbi small cap fund

canara robeco mutual fund a/c canara robeco small cap fund

motilal oswal small cap fund

Annual Reports:

News Update:

Rossari Biotech’s arm commissions 15000 MTPA ethoxylation capacity at Dahej facility
29th Sep 2025, 10:30 AM

The second phase of the expansion is expected to be completed by Q3 FY26
Read More
Rossari Biotech - Quarterly Results
19th Jul 2025, 19:34 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback